Applications open for Antimicrobial Resistance Research Capital Funding

14 November 2018

Resistance to all antimicrobials, and especially bacterial resistance to existing antibiotics, is increasing. It is now posing a serious threat to health both in the UK and globally and risks undermining the major improvements in medicine that have been achieved in recent decades.

In response to this public health challenge, in 2013 the Government published a five year UK AMR Strategy aiming to improve the knowledge and understanding of antimicrobial resistance (AMR), to conserve and steward the effectiveness of existing treatments, and to stimulate the development of new antibiotics, diagnostics and novel therapies.

In response to Lord O’Neill’s Independent Review on AMR, the Government set out a number of specific ambitions to measure progress on tackling AMR and also committed additional investment.

As part of this, on behalf of the Department of Health and Social Care (DHSC), the NIHR has launched an open competition to allocate up to £32 million of DHSC funding to provide capital investment including any associated costs for AMR research. Seed funding costs to cover initial pilot and/or scoping studies may also be included in the application.

All NHS Trusts, Higher Education Institutions and not-for-profit UK research organisations (including the NHS and public sector agencies and research establishments) within the UK are eligible to apply.

Funding will be awarded for a two-year period starting on 1 April 2019. All funding provided to successful applicants must be spent by 31 March 2021.

Applications should be submitted by 6 December 2018 at 13:00. For more information and to apply, please click here

MUK AD_0.jpg

MWM-Awards-18.gif